OSCR
Oscar Health, Inc.NYSEHealthcare$11.92+1.62%ClosedMarket Cap: $3.09B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.70
P/S
0.28
EV/EBITDA
-2.47
DCF Value
$-168.81
FCF Yield
32.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.4%
Operating Margin
-3.4%
Net Margin
-3.8%
ROE
-39.5%
ROA
-7.0%
ROIC
-27.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.81B | 6.6% | $-333.7M | $-352.6M | $-1.24 | — |
| FY 2025 | $11.70B | 14.4% | $-396.4M | $-443.2M | $-1.69 | — |
| Q3 2025 | $2.99B | 13.4% | $-129.3M | $-137.4M | $-0.53 | — |
| Q2 2025 | $2.86B | 10.9% | $-230.5M | $-228.4M | $-0.84 | — |
| Q1 2025 | $3.05B | 25.8% | $297.1M | $275.3M | $0.92 | — |
| Q4 2024 | $2.39B | 13.7% | $-147.7M | $-153.5M | $-0.62 | — |
| FY 2024 | $9.18B | 20.1% | $57.3M | $25.4M | $0.10 | — |
| Q3 2024 | $2.42B | 100.0% | $-52.3M | $-54.6M | $-0.22 | — |
| Q2 2024 | $2.22B | 100.0% | $60.9M | $56.2M | $0.18 | — |
| Q1 2024 | $2.14B | 100.0% | $178.5M | $177.4M | $0.62 | — |
| Q4 2023 | $1.43B | 100.0% | $-150.6M | $-150.0M | $-0.66 | — |
| FY 2023 | $5.86B | 20.8% | $-235.6M | $-270.7M | $-1.22 | — |